MTOR and melanoma: Taken together, our findings indicate that mTOR, bile acid metabolism, and peroxisome metabolic pathways are coordinately dysregulated and highly upregulated in the CD8+ TILs of melanoma and SCC patients, impacting the capacity of the host immune system to suppress and eradicate tumor cells.